(Q44429534)

2 December 2017

title

Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats (English)

1 reference

2 December 2017

0 references

James J Devenny

1

1 reference

2 December 2017

Helen E Godonis

2

1 reference

2 December 2017

Susan J Harvey

3

1 reference

2 December 2017

Suzanne Rooney

4

1 reference

2 December 2017

Mary J Cullen

5

1 reference

2 December 2017

Mary Ann Pelleymounter

6

1 reference

2 December 2017

publication date

8 March 2012

1 reference

2 December 2017

1 reference

2 December 2017

volume

20

1 reference

2 December 2017

issue

8

1 reference

2 December 2017

page(s)

1645-1652

1 reference

Exercise in a pill: feasibility of energy expenditure targets

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Molecular physiology of weight regulation in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Glucose control by the kidney: an emerging target in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Molecular Analysis of the SGLT2 Gene in Patients with Renal Glucosuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Expression and functionality of the Na+/myo-inositol cotransporter SMIT2 in rabbit kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Identification of a novel Na+/myo-inositol cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Cloning and expression of bovine sodium/glucose cotransporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Kinetics and specificity of the renal Na+/myo-inositol cotransporter expressed in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Localization and rapid regulation of Na+/myo-inositol cotransporter in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Glucose transporters: structure, function and consequences of deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Animal models for the study of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Hypothalamic nutrient sensing and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Obesity and the environment: where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Renal Na(+)-glucose cotransporters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

Body temperature regulation and thermoneutrality in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.59

31 March 2020

Identifiers

DOI

10.1038/OBY.2012.59

1 reference

release_q3dxjyi6a5brxphhz3bmw2hpyu

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q3dxjyi6a5brxphhz3bmw2hpyu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference